61 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author신진호-
dc.date.accessioned2018-03-06T00:11:41Z-
dc.date.available2018-03-06T00:11:41Z-
dc.date.issued2013-10-
dc.identifier.citationJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,2013,62(18), p B49-B49en_US
dc.identifier.issn0735-1097-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0735109713042861?via%3Dihub-
dc.identifier.urihttp://hdl.handle.net/20.500.11754/42765-
dc.description.abstractHigh platelet reactivity (HPR) is associated with poor prognosis in coronary artery disease. Recently PLATO subgroup analysis showed that ticagrelor is better clinical outcome than the clopidogrel, which was related with low HPR. Also many studies reported that adjunctive cilostazol to dual antiplatelet therapy (DAPT) (so called triple antiplatelet therapy; TAT) is better clinical outcome than DAPT, which was associated with a greater antiplatelet effect at 30 days. Thus, this study was designed to compare the effect of ticagrelor and TAT on platelet reactivity with PRU and ARU values.en_US
dc.description.sponsorshipThis study was composed of total 65 patients underwent the coronary stenting. All patients received a 600-mg loading dose of clopidogrel or a 180-mg loading dose of ticagrelor and concomitant aspirin therapy. After patients underwent coronary stenting, they were nonrandomly assigned to 1 of 4 groups: DAPT group (n=15), clopidogrel of 75 mg daily; ticagrelor group (n=20), ticagrelor of 180 mg daily; TAT group (n=15), adjunctive cilostazol of 100 mg twice daily to clopidogrel of 75 mg daily; and triple switch group (n=15), switch of ticagrelor to TAT since 3rd day. The platelet reactivity was assessed by ARU and PRU values at day 2 and day 7, respectively.en_US
dc.language.isoenen_US
dc.publisherELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USAen_US
dc.subjectCardiacen_US
dc.subjectCardiovascular Systemsen_US
dc.subjectCardiologyen_US
dc.titleComparison of effect that ticagrelor and triple antiplatelet therapy affect platelet reactivityen_US
dc.typeArticleen_US
dc.relation.no18-
dc.relation.volume62-
dc.identifier.doi10.1016/j.jacc.2013.08.886-
dc.relation.page49-49-
dc.relation.journalJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY-
dc.contributor.googleauthorChoe, Seong-Il-
dc.contributor.googleauthorKim, Soon-Gil-
dc.contributor.googleauthorKim, Jeung-Hyeun-
dc.contributor.googleauthorShin, Jin-Ho-
dc.relation.code2013011018-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidjhs2003-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE